Updated Publication of Remdesivir guidance for patients hospitalised with Covid-19 (adults and children aged 12 years and older)(version 3; updated 14/6/21)

This updated NHS Interim Clinical Commissioning Policy now includes consideration of a course of remdesivir with dexamethasone as standard of care in re-admitted patients, patients with end-stage renal disease on haemodialysis and significantly immunocompromised patients.

Source:

Medicines and Healthcare products Regulatory Agency